Alterations in lipid metabolism accompanied by changes in protein and carotenoid content as spectroscopic markers of human T cell activation.

Carotenoids Confocal Raman microscopy Lipids Molecular imaging Stimulated Raman scattering T cell activation

Journal

Biochimica et biophysica acta. Molecular and cell biology of lipids
ISSN: 1879-2618
Titre abrégé: Biochim Biophys Acta Mol Cell Biol Lipids
Pays: Netherlands
ID NLM: 101731727

Informations de publication

Date de publication:
20 Apr 2024
Historique:
received: 23 08 2023
revised: 28 03 2024
accepted: 09 04 2024
medline: 23 4 2024
pubmed: 23 4 2024
entrez: 22 4 2024
Statut: aheadofprint

Résumé

This work aims to understand better the mechanism of cellular processes accompanying the activation of human T cells and to develop a novel, fast, label-free approach to identify molecular biomarkers for this process. Non-activated T-cell activation is a key method in cancer immunotherapy and involves the isolation of T-cells from a patient to perform a specific genetic modification. The standard methodology for confirming the activation state of T cells is based on flow cytometry, antibodies, and target antigens that provide high specificity detection but may show background staining or specific secondary antibody reactions. Here, we evaluated the potential of Raman-based molecular imaging in differentiating non-activated and activated human T cells. Confocal Raman microscopy was performed on activated T cells using chemometrics to obtain comprehensive molecular information, while Stimulated Raman Scattering imaging was used to quickly provide high-resolution images of selected cellular components of activated and non-activated cells. For the first time, carotenoids, lipids, and proteins were shown to be important biomarkers of T-cell activation. We found that T-cell activation was accompanied by lipid accumulation and loss of carotenoid content. Our findings on the biochemical, morphological, and structural changes associated with activated mature T cells provide insights into the molecular changes that occur during therapeutic manipulation of the immune response. The methodology for identifying activated T cells is based on a novel imaging method and supervised and unsupervised chemometrics. It unambiguously identifies specific and unique molecular changes without the need for staining, fixation, or any other sample preparation.

Identifiants

pubmed: 38649008
pii: S1388-1981(24)00046-5
doi: 10.1016/j.bbalip.2024.159496
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

159496

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Aleksandra Borek-Dorosz (A)

Jagiellonian University in Kraków, Faculty of Chemistry, Department of Chemical Physics, Krakow, Poland.

Anna Maria Nowakowska (AM)

Jagiellonian University in Kraków, Faculty of Chemistry, Department of Chemical Physics, Krakow, Poland.

Paulina Laskowska (P)

Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.

Maciej Szydłowski (M)

Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.

William Tipping (W)

Department of Pure and Applied Chemistry, Technology and Innovation Centre, University of Strathclyde, Glasgow, United Kingdom.

Duncan Graham (D)

Department of Pure and Applied Chemistry, Technology and Innovation Centre, University of Strathclyde, Glasgow, United Kingdom.

Katarzyna Wiktorska (K)

Department of Physics and Biophysics, Institute of Biology, Warsaw University of Life Sciences, Warsaw, Poland.

Przemyslaw Juszczynski (P)

Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.

Malgorzata Baranska (M)

Jagiellonian University in Kraków, Faculty of Chemistry, Department of Chemical Physics, Krakow, Poland; Jagiellonian University in Kraków, Jagiellonian Centre for Experimental Therapeutics, Krakow, Poland.

Piotr Mrowka (P)

Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland; Department of Biophysics, Physiology and Pathophysiology, Medical University of Warsaw, Warsaw, Poland. Electronic address: pmrowka@ihit.waw.pl.

Katarzyna Majzner (K)

Jagiellonian University in Kraków, Faculty of Chemistry, Department of Chemical Physics, Krakow, Poland. Electronic address: katarzyna.b.majzner@uj.edu.pl.

Classifications MeSH